Spoken Alpha
Biofrontera Inc.
Biofrontera Inc. develops and commercializes pharmaceutical products for treating dermatological conditions, primarily through photodynamic therapy.
Biofrontera Inc.
Most recent reported earnings: Q1 FY2021 (Jun 29, 2021).
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add BFRIW, reply to your welcome email and we'll prioritize it.
History
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for BFRIW.
$ curl https://api.spokenalpha.com/v1/companies/BFRIWFAQ
Spoken Alpha indexes BFRIW's earnings call transcripts at https://spokenalpha.com/companies/BFRIW. Each call links to attributed speakers and parsed analyst Q&A. Biofrontera Inc.'s own investor relations page is at https://investors.biofrontera-us.com/.
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q1 FY2021 | 2021-06-29 | $-0.46 | $0.00 | — | $4.7M | — | — | EODHD |
| Q4 FY2020 | 2021-03-30 | $-0.44 | $0.00 | — | $8.6M | — | — | EODHD |
| Q3 FY2020 | 2020-12-30 | $-0.20 | $0.00 | — | $3.3M | — | — | EODHD |
| Q2 FY2020 | 2020-09-29 | $-0.20 | $0.00 | — | $2.4M | — | — | EODHD |
Source: EODHD. BFRIW reported actuals as published; sparse fields render as —.